Cheol Keun Park1, Hyun-Soo Kim2. 1. Department of Pathology, Armed Forces Capital Hospital, Seongnam, Republic of Korea. 2. Department of Pathology, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea hyunsookim@yuhs.ac.
Abstract
BACKGROUND/AIM: A subset of carcinomas metastatic to the ovary can exhibit growth patterns closely resembling ovarian mucinous cystadenoma and borderline tumor. They can be misinterpreted as underlying primary ovarian mucinous tumors and can be erroneously used to suggest that the carcinomatous component arises from mucinous precursor lesions. MATERIALS AND METHODS: We investigated the clinicopathological characteristics of 11 cases of metastatic carcinoma that had metastasized from colorectal and pancreatobiliary carcinoma and mimicked primary ovarian mucinous tumors. RESULTS: The patient age ranged from 37 to 81 years old. Seven patients presented to gynecologists with non-specific pelvic symptoms similar to those of primary ovarian tumors. The primary tumor was identified before the detection of the ovarian lesion in 6 cases, synchronously in 5, and postoperatively in 1 case. The ovarian tumors were bilateral in 6 cases. The greatest dimension of the metastatic tumors ranged from 4.8 to 23.0 cm. Multinodularity was present in 7 cases, and surface involvement was identified in 5 cases. An infiltrative growth pattern was present, at least focally, in 8 cases. Six and 2 cases exhibited cystadenomatous and borderline-like growth patterns, respectively. CONCLUSION: Although the diagnosis of metastatic tumors to the ovary is possible in most cases on the basis of clinical presentation and standard diagnostic criteria, their differential diagnosis may be problematic because of morphological patterns that strikingly overlap with those of primary ovarian benign, borderline, and malignant mucinous tumors. The possibility of metastases should be considered when evaluating ovarian mucinous tumors. Copyright
BACKGROUND/AIM: A subset of carcinomas metastatic to the ovary can exhibit growth patterns closely resembling ovarian mucinous cystadenoma and borderline tumor. They can be misinterpreted as underlying primary ovarian mucinous tumors and can be erroneously used to suggest that the carcinomatous component arises from mucinous precursor lesions. MATERIALS AND METHODS: We investigated the clinicopathological characteristics of 11 cases of metastatic carcinoma that had metastasized from colorectal and pancreatobiliary carcinoma and mimicked primary ovarian mucinous tumors. RESULTS: The patient age ranged from 37 to 81 years old. Seven patients presented to gynecologists with non-specific pelvic symptoms similar to those of primary ovarian tumors. The primary tumor was identified before the detection of the ovarian lesion in 6 cases, synchronously in 5, and postoperatively in 1 case. The ovarian tumors were bilateral in 6 cases. The greatest dimension of the metastatic tumors ranged from 4.8 to 23.0 cm. Multinodularity was present in 7 cases, and surface involvement was identified in 5 cases. An infiltrative growth pattern was present, at least focally, in 8 cases. Six and 2 cases exhibited cystadenomatous and borderline-like growth patterns, respectively. CONCLUSION: Although the diagnosis of metastatic tumors to the ovary is possible in most cases on the basis of clinical presentation and standard diagnostic criteria, their differential diagnosis may be problematic because of morphological patterns that strikingly overlap with those of primary ovarian benign, borderline, and malignant mucinous tumors. The possibility of metastases should be considered when evaluating ovarian mucinous tumors. Copyright
Authors: Pavel Dundr; Barbora Bazalová; Michaela Bártů; Tjalling Bosse; Jana Drozenová; Pavel Fabian; Oluwole Fadare; Jitka Hausnerová; Radek Jakša; Jan Laco; Sigurd F Lax; Radoslav Matěj; W Glenn McCluggage; Gábor Méhes; Romana Michálková; Kristýna Němejcová; Naveena Singh; Simona Stolnicu; Petr Škapa; Marián Švajdler; Ivana Stružinská Journal: Virchows Arch Date: 2022-05-13 Impact factor: 4.535
Authors: Catherine M Tucker; Cheryl L Godcharles; Wei Jiang; Charles J Yeo; Norman G Rosenblum; Ethan J Halpern; William E Luginbuhl; Anthony J Prestipino Journal: J Pancreat Cancer Date: 2021-10-14